B
2.28
-0.09 (-3.80%)
| Previous Close | 2.37 |
| Open | 2.41 |
| Volume | 1,857,689 |
| Avg. Volume (3M) | 1,208,852 |
| Market Cap | 289,161,920 |
| Price / Earnings (Forward) | 106.38 |
| Price / Sales | 0.770 |
| Price / Book | 2.91 |
| 52 Weeks Range | |
| Earnings Date | 7 Aug 2025 |
| Profit Margin | -11.94% |
| Operating Margin (TTM) | -17.28% |
| Diluted EPS (TTM) | -0.340 |
| Quarterly Revenue Growth (YOY) | -14.50% |
| Quarterly Earnings Growth (YOY) | -94.00% |
| Total Debt/Equity (MRQ) | 1,232.44% |
| Current Ratio (MRQ) | 7.47 |
| Operating Cash Flow (TTM) | 35.98 M |
| Levered Free Cash Flow (TTM) | 46.98 M |
| Return on Assets (TTM) | -5.17% |
| Return on Equity (TTM) | -70.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Household & Personal Products (US) | Bearish | Bearish |
| Household & Personal Products (Global) | Bearish | Bearish | |
| Stock | The Beauty Health Company | Bullish | Bullish |
AIStockmoo Score
-0.5
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.50 |
|
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products. |
|
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Investment Style | Small Value |
| % Held by Insiders | 10.07% |
| % Held by Institutions | 83.93% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Mirabella Financial Services Llp | 30 Jun 2025 | 12,861,549 |
| Silver Point Capital L.P. | 30 Jun 2025 | 1,592,030 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 3.50 (Roth Capital, 53.51%) | Buy |
| Median | 3.00 (31.58%) | |
| Low | 2.50 (TD Cowen, 9.65%) | Hold |
| Average | 3.00 (31.58%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 2.28 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| TD Cowen | 22 Sep 2025 | 2.50 (9.65%) | Hold | 2.28 |
| Roth Capital | 19 Sep 2025 | 3.50 (53.51%) | Buy | 2.28 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 30 Sep 2025 | Announcement | The Beauty Health Company Names Pedro Malha President and Chief Executive Officer |
| 23 Sep 2025 | Announcement | Hydrafacial Joins Cosmopolitan Readers’ Choice Hall of Fame as Three-Time Winner for Best Pro Facial |
| 09 Sep 2025 | Announcement | MULTIMEDIA UPDATE -- Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth |
| 09 Sep 2025 | Announcement | Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth |
| 07 Aug 2025 | Announcement | BeautyHealth Reports Second Quarter 2025 Financial Results |
| 24 Jul 2025 | Announcement | BeautyHealth to Report Second Quarter 2025 Financial Results on August 7, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |